Growth of Poorly Differentiated Endometrial Carcinoma Is Inhibited by Combined Action of Medroxyprogesterone Acetate and the Ras Inhibitor Salirasib
Oncotarget - United States
doi 10.18632/oncotarget.867
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2013
Authors
Publisher
Impact Journals, LLC